Skip to main content
. 2015;3(3):193–201.

Table 3.

Univariable survival analyses

Variable HR (95% CI) p value
Age 1.02 (0.96, 1.08) 0.51
Gender
Female: male
1.24 (0.44, 3.51) 0.69
Race
Not Caucasian: Caucasian
0.88 (0.25, 3.14) 0.85
BMI 0.91 (0.82, 1.02) 0.11
Smoking status 0.005
Former: current 1.53 (0.42, 5.58)
Never: current 21.0 (1.76, 251)
Pack years 0.99 (0.97, 1.01) 0.38
CCI 3-6: CCI 0-2 1.28 (0.45, 3.60) 0.65
Tumor size 1.33 (0.99, 1.78) 0.050
SUV 0.98 (0.91, 1.07) 0.66
FEV1, % predicted 1.01 (0.99, 1.03) 0.37
DLCO, % predicted 0.98 (0.95, 1.02) 0.38
Histology 0.95
Squamous: adenocarcinoma 1.08 (0.29, 4.02)
Small cell: adenocarcinoma 1.80 (0.21, 15.6)
Clinical stage 0.093
IB: IA 1.19 (0.32, 4.45)
IIA: IA 3.93 (1.04, 14.8)
KPS 0.95 (0.91, 1.00) 0.055
Local failure 1.04 (0.12, 8.77) 0.97
Total dose 0.98 (0.93, 1.03) 0.47
Fractions 1.12 (0.83, 1.52) 0.45
Pre-6MWT SBP 1.00 (0.97, 1.02) 0.77
Pre-6MWT DBP 0.96 (0.91, 1.01) 0.15
Post-6MWT SBP 0.98 (0.95, 1.00) 0.10
Post-6MWT DBP 0.94 (0.90, 0.99) 0.014
Resting HR 0.98 (0.94, 1.02) 0.35
6MWD 0.999 (0.997, 1.001) 0.50
6MWD, % pred 1.00 (0.97, 1.03) 0.88
BDS 1.33 (1.04, 1.69) 0.018
HR during 6MWT 0.98 (0.94, 1.01) 0.19
HR-1 min after 6MWT 1.00 (0.96, 1.03) 0.85
HRR 1.08 (0.998, 1.16) 0.054
Impaired HRR 11.0 (1.42, 84.4) 0.004

CI = confidence interval; HR = hazard ratio; 6MWD = 6-minute walk distance; 6MWT = 6-minute walk test; BDS = Borg dyspnea score; BMI = body-mass index; CCI = Charlson comorbidity index; DBP = diastolic blood pressure; DLCO = diffusion capacity of carbon monoxide; FEV1 = forced expiratory volume within 1 second; HR = heart rate; HRR = heart rate recovery; KPS = Karnofsky performance status; LLL = left lower lobe; LUL = left upper lobe; RLL = right lower lobe; RML = right middle lobe; RUL = right upper lobe; SBP = systolic blood pressure; SUV = standardized uptake value